Review
Accepted on 07 Sep 2024
A comprehensive review of finerenonea third-generation non-steroidal mineralocorticoid receptor antagonist
in Cardiovascular Pharmacology and Drug Discovery
Review
Accepted on 07 Sep 2024
in Cardiovascular Pharmacology and Drug Discovery
Original Research
Accepted on 06 Sep 2024
in Ophthalmology
Systematic Review
Accepted on 06 Sep 2024
in Translational Medicine
Original Research
Accepted on 06 Sep 2024
in Public Health Education and Promotion
Original Research
Accepted on 06 Sep 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 06 Sep 2024
in Educational Psychology
Review
Accepted on 06 Sep 2024
in Regulatory Science
Original Research
Accepted on 06 Sep 2024
in Forensic and Legal Psychology
Original Research
Accepted on 06 Sep 2024
in Primary Immunodeficiencies
Original Research
Accepted on 06 Sep 2024
in Antibiotic Resistance and New Antimicrobial drugs
Case Report
Accepted on 06 Sep 2024
in Cancer Immunity and Immunotherapy
Curriculum, Instruction, and Pedagogy
Accepted on 06 Sep 2024
in Language, Culture and Diversity
Original Research
Accepted on 06 Sep 2024
in Hypertension
Original Research
Accepted on 06 Sep 2024
in Nephrology
Review
Accepted on 06 Sep 2024
in Pulmonary Medicine
Brief Research Report
Accepted on 06 Sep 2024
in Language, Culture and Diversity